Total 340B Purchases to Reach $16B by 2019: Four Drivers of the Program's Growth

A recent article cites Aaron Vandervelde‘s paper Growth of the 340B Program. The paper reviews trends and topics surrounding the 340B discount drug program, including a forecast of future trends. 

Read the full article.